SII appeals to PMO with proposed reforms for the drug regulatory system
Pune-based Serum Institute of India has a written a letter to the Prime Minister’s Office (PMO) with proposed reforms which can be implemented in the drug regulatory system, which comprises of giving permit for manufacturing and stockpiling of non-Covid vaccines while subjected to clinical trials. Prakash Kumar Singh, Director of Government and Regulatory Affairs, Serum…